Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery

Clinical trial NCT03361436 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03361436
Sponsor: OHSU Knight Cancer Institute
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Liposarcoma Malignant Abdominal Neoplasm Malignant Retroperitoneal Neoplasm Malignant Scrotal Neoplasm Malignant Solid Neoplasm Malignant Spermatic Cord Neoplasm

Start date: 2018-03-19
Primary completion: 2023-02-14
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.